Medication info
Arover Tablets (Acyclovir)

Arover Tablets (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Os Korea Pharmaceutical Co., Ltd.
Appearance
Light blue, round tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 202000743 · Approved 2020.02.07 · Insurance code 629701940

Summary

Main use
Treatment of herpes zoster and herpes simplex; prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose, 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to begin administration as soon as possible after infection. In recurrent cases, administration is recommended at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose, 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose, 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal absorption disorders, intravenous administration should be considered. 3) It is best to begin administration as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; therefore, use caution, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg of this medicine per dose, twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg of this medicine per dose, 3 times daily at approximately 8-hour intervals.
Child administration
1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Age 2 years and older: Same as the adult dose. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years of age: Administer 1/2 of the adult dose. Reliable data are not yet available on the prevention of herpes simplex virus infections in immunocompetent patients. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose), 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours of rash onset if possible.

Ingredients

Manufacturer
Os Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster and herpes simplex; prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Genital herpes
  • herpes virus infection of the skin and mucous membranes
  • shingles virus infection
  • acute pain
  • chickenpox
View approved original text

This medicine is used for the treatment and prevention of herpes virus infections, including primary and recurrent genital herpes. It is also effective for the treatment of acute pain due to shingles virus infections and is used for the treatment of chickenpox in children over 2 years of age. It helps to improve symptoms associated with various viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose, 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to begin administration as soon as possible after infection. In recurrent cases, administration is recommended at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose, 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose, 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal absorption disorders, intravenous administration should be considered. 3) It is best to begin administration as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; therefore, use caution, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg of this medicine per dose, twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg of this medicine per dose, 3 times daily at approximately 8-hour intervals.

Child administration

1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Age 2 years and older: Same as the adult dose. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years of age: Administer 1/2 of the adult dose. Reliable data are not yet available on the prevention of herpes simplex virus infections in immunocompetent patients. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose), 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours of rash onset if possible.

Precautions

This drug should not be used in patients who are allergic to this drug or its ingredients. Patients with poor kidney function may experience psychiatric and neurological symptoms while using this drug, so caution is necessary. Patients with impaired liver function should use this drug with caution as liver function may worsen. In infants or children, it should only be administered as minimally necessary, and special caution should be taken for newborns or low birth weight infants as safety has not been established. Elderly patients are more likely to have reduced kidney function, which may lead to increased drug concentration, so dosing and intervals should be adjusted along with adequate hydration. If signs of allergic reactions, skin rashes, fever, or hives occur while taking this medication, it should be stopped immediately, and medical consultation should be sought. Serious allergic reactions, such as shock, may rarely occur, and if symptoms such as low blood pressure, difficulty in breathing, or chest tightness appear, treatment should be stopped immediately, and emergency care should be received. Neuropsychiatric side effects may include impaired consciousness, confusion, hallucinations, seizures, drowsiness, etc., which may be more frequent in patients with kidney dysfunction or the elderly, so caution is advised. Kidney function may be impaired, so if hematuria or proteinuria appears, inform the healthcare provider. Abnormal liver function, gastrointestinal symptoms (nausea, vomiting, abdominal pain), blood abnormalities (anemia, thrombocytopenia, etc.), skin symptoms may occur, so report any abnormal symptoms immediately. If symptoms do not improve or worsen while taking this drug, other treatment methods should be considered, and particularly, treatment for shingles or chickenpox should be started as soon as possible after symptom onset. During treatment, adequate hydration should be maintained to reduce the risk of dehydration and kidney toxicity. This drug may harm the fetus during pregnancy, so it should only be used when absolutely necessary, and breastfeeding should be discontinued since this drug can be transmitted through breast milk. Drug interactions may occur when taken with other medications, so particular caution is required when taking drugs that affect kidney function or certain other drugs concurrently. Overdose may lead to kidney damage or central nervous system symptoms, and if overdose is suspected, contact a healthcare provider immediately and receive appropriate treatment. Caution should be exercised during activities involving risk, such as driving or operating machinery.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitive reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 115 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration impairment
  • aggressive behavior
  • depersonalization
  • agitation
  • ataxia
  • coma
  • confusion
  • delirium
  • stammering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • dyskinesia
  • nystagmus
  • renal failure
  • crystalluria
  • increased BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary erythrocyte casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • upper abdominal pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • generalized fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urethral obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • dyspnea
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • agitation
  • coma
  • somnolence
  • confusion
  • seizure
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Storing at room temperature between 1 degree and 30 degrees is recommended. This will help maintain the effectiveness of the drug safely for a long time.

Appearance and packaging

Appearance

Light blue, round tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.